72
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development of thermosensitive liposome-containing in-situ gel systems for intranasal administration of thiocolchicoside and in vivo evaluation in a rabbit model

, &
Received 06 Jan 2024, Accepted 03 Jun 2024, Published online: 13 Jun 2024

References

  • Aisha AFA, Majid AMSA, Ismail Z. 2014. Preparation and characterization of nano liposomes of Orthosiphon stamineusethanolic extract in soybean phospholipids. BMC Biotechnol. 14(1):23. doi: 10.1186/1472-6750-14-23.
  • Aksu NB, Yozgatlı V, Okur ME, Ayla Ş, Yoltaş A, Üstündağ Okur N. 2019. Preparation and evaluation of QbD based fusidic acid loaded in situ gel formulations for burn wound treatment. J Drug Delivery Sci Technol. 52:110–121. doi: 10.1016/j.jddst.2019.04.015.
  • Almeida H, Amaral MH, Lobão P, Lobo JM. 2013. Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogels. Curr Drug Deliv. 10(6):753–764.
  • Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, Zandieh-Doulabi B. 2018. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review. International Journal of Polymeric Materials and Polymeric Biomaterials. 67(6):383–400. doi: 10.1080/00914037.2017.1332623.
  • Andrews GP, Laverty TP, Jones DS. 2009. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 71(3):505–518. doi: 10.1016/j.ejpb.2008.09.028.
  • Artusi M, Nicoli S, Colombo P, Bettini R, Sacchi A, Santi P. 2004. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J Pharm Sci. 93(10):2431–2438. doi: 10.1002/jps.20152.
  • Artusi M, Santi P, Colombo P, Junginger HE. 2003. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm. 250(1):203–213. doi: 10.1016/s0378-5173(02)00545-8.
  • Bakonyi M, Berkó S, Budai-Szűcs M, Kovács A, Csányi E. 2017. DSC for evaluating the encapsulation efficiency of lidocaine-loaded liposomes compared to the ultracentrifugation method. J Therm Anal Calorim. 130(3):1619–1625. doi: 10.1007/s10973-017-6394-1.
  • Baranauskaite-Ortasöz JUB, Marksiene J. 2021. Chapter 5: intranasal in situ gel as a promising approach for enhancing bioavailability and brain delivery. Updates in Internal Sciences for 2021. G. R. K. S; p. 87–108, IKSAD Publishing House. Ankara, Turkey.
  • Baranauskaite-Ortasöz J, Üner B. 2022. Preparation and characterization studies of nanofiber and orodispersable film formulations of enoxolone. Journal of Research in Pharmacy. 26(5): 1242–1251.
  • Begum M, Abbulu K, Sudhakar M. 2012. Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution. J Young Pharm. 4(4):209–219. doi: 10.4103/0975-1483.104364.
  • Buclin T, Cosma Rochat M, Burckhardt P, Azria M, Attinger M. 2002. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers. J Bone Miner Res. 17(8):1478–1485. doi: 10.1359/jbmr.2002.17.8.1478.
  • Carta M, Murru L, Botta P, Talani G, Sechi G, De Riu P, Sanna E, Biggio G. 2006. The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system. Neuropharmacology. 51(4):805–815. doi: 10.1016/j.neuropharm.2006.05.023.
  • Charcosset C, Juban A, Valour J, Urbaniak S, Fessi H. 2015. Preparation of liposomes at large scale using the ethanol injection method: effect of scale-up and injection devices. Chem Eng Res Des. 94:508–515. doi: 10.1016/j.cherd.2014.09.008.
  • Chaudhary B, Verma S. 2014. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections. Sci World J. 2014:280927–280928. doi: 10.1155/2014/280928.
  • Costa AP, Xu X, Burgess DJ. 2014. Freeze-anneal-thaw cycling of unilamellar liposomes: effect on encapsulation efficiency. Pharm Res. 31(1):97–103. doi: 10.1007/s11095-013-1135-z.
  • Cui Z, Mumper RJ. 2002. Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharm Res. 19(12):1901–1906. doi: 10.1023/a:1021462012442.
  • Dhakar RC. 2011. Non-invasive systemic drug delivery via nasal route: a review.
  • Ding W, Li Y, Hou X, Li G. 2016. Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system. Drug Deliv. 23(1):88–94. doi: 10.3109/10717544.2014.905651.
  • Dixit R, Verma A, Singh UP, Soni S, Mishra AK, Bansal AK, Pandit JK. 2011. Preparation and characterization of gellan-chitosan polyelectrolyte complex beads. Lat Am J Pharm. 30(6):1186–1195.
  • Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RFV. 2010. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm. 75(2):186–193. doi: 10.1016/j.ejpb.2010.02.011.
  • Honary S, Zahir F. 2013. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2.)Trop J Pharm Res. 12(2):265–273. doi: 10.4314/tjpr.v12i2.20.
  • Hong SS, Oh KT, Choi HG, Lim SJ. 2019. Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives. Pharmaceutics. 11(10):540. doi: 10.3390/pharmaceutics11100540.
  • Horowitz AT, Barenholz Y, Gabizon AA. 1992. In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim Biophys Acta. 1109(2):203–209. doi: 10.1016/0005-2736(92)90084-y.
  • ICH. 2005. Guideline: Validation of analytical procedures: text and methodology Q2 (R1). Geneva, 1-13.
  • Jamshidnejad-Tosaramandani T, Kashanian S, Karimi I, Schiöth HB. 2023. Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media. Front Pharmacol. 14:1227423. doi: 10.3389/fphar.2023.1227423.
  • Jelvehgari M, Montazam H. 2011. Evaluation of mechanical and rheological properties of metronidazole gel as local delivery system. Arch Pharm Res. 34(6):931–940. doi: 10.1007/s12272-011-0610-5.
  • Karolewicz B, Górniak A, Owczarek A, Żurawska-Płaksej E, Piwowar A, Pluta J. 2014. Thermal, spectroscopic, and dissolution studies of ketoconazole–Pluronic F127 system. J Therm Anal Calorim. 115(3):2487–2493. doi: 10.1007/s10973-014-3661-2.
  • Keck T, Leiacker R, Riechelmann H, Rettinger G. 2000. Temperature profile in the nasal cavity. Laryngoscope. 110(4):651–654. doi: 10.1097/00005537-200004000-00021.
  • Kumar D, Ali J, Baboota S. 2016. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies. Drug Deliv. 23(2):591–600. doi: 10.3109/10717544.2014.916764.
  • Larsson M, Hill A, Duffy J. 2012. Suspension stability; why particle size, zeta potential and rheology are important. Annual Transactions of the Nordic Rheology Society. 20(2012):6.
  • Lin B, Zhou S. 2017. Poly (ethylene glycol)-grafted silica nanoparticles for highly hydrophilic acrylic-based polyurethane coatings. Prog Org Coat. 106:145–154. doi: 10.1016/j.porgcoat.2017.02.008.
  • Mohammadi ZA, Aghamiri SF, Zarrabi A, Talaie MR. 2016. Liposomal doxorubicin delivery systems: effects of formulation and processing parameters on drug loading and release behavior. Curr Drug Deliv. 13(7):1065–1070. doi: 10.2174/1567201813666151228104643.
  • Mura P, Mennini N, Nativi C, Richichi B. 2018. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Eur J Pharm Biopharm. 122:54–61. doi: 10.1016/j.ejpb.2017.10.008.
  • Narayan R, Singh M, Ranjan O, Nayak Y, Garg S, Shavi GV, Nayak UY. 2016. Development of risperidone liposomes for brain targeting through intranasal route. Life Sci. 163:38–45. doi: 10.1016/j.lfs.2016.08.033.
  • Ng SF, Rouse J, Sanderson D, Eccleston G. 2010. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cells. Pharmaceutics. 2(2):209–223. doi: 10.3390/pharmaceutics2020209.
  • Nie S, Hsiao WLW, Pan W, Yang Z. 2011. Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomedicine. 6:151–166. doi: 10.2147/IJN.S15057.
  • Ockun MA, Baranauskaite J, Uner B, Kan Y, Kırmızıbekmez H. 2022. Preparation, characterization and evaluation of liposomal-freeze dried anthocyanin-enriched Vaccinium arctostaphylos L. fruit extract incorporated into fast dissolving oral films. J Drug Delivery Sci Technol. 72:103428. doi: 10.1016/j.jddst.2022.103428.
  • Üstündağ Okur N, Yoltaş A, Yozgatli V. 2016. Development and characterization of voriconazole loaded in situ gel formulations for ophthalmic application/Okuler Uygulama icin Vorikonazol Yuklu In Situ Jel Formulasyonlarinin Gelistirilmesi ve Karakterizasyonu. tjps. 13(3):311–317. +. doi: 10.4274/tjps.2016.05.
  • Omar M, Eleraky E, El Sisi M, Ali Hasan O. 2019. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: design, optimization, in vitro and in vivo evaluation. Drug Des Devel Ther. 13:4413–4430. doi: 10.2147/DDDT.S235004.
  • Ong SG, Ming LC, Lee KS, Yuen KH. 2016. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 8(3):25. doi: 10.3390/pharmaceutics8030025.
  • Pham TT, Jaafar-Maalej C, Charcosset C, Fessi H. 2012. Liposome and niosome preparation using a membrane contactor for scale-up. Colloids Surf, B. 94:15–21. doi: 10.1016/j.colsurfb.2011.12.036.
  • Pilch E, Musiał W. 2018. Selected physicochemical properties of lyophilized hydrogel with liposomal fraction of calcium dobesilate. Materials (Basel). 11(11):2143. doi: 10.3390/ma11112143.
  • Puech C, Hodin S, Forest V, He Z, Mismetti P, Delavenne X, Perek N. 2018. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies. Int J Pharm. 551(1–2):281–289. doi: 10.1016/j.ijpharm.2018.09.040.
  • Radhofer-Welte S, Dittrich P. 1998. Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J Chromatogr B Biomed Sci Appl. 707(1-2):151–159. doi: 10.1016/s0378-4347(97)00597-5.
  • Rajput AP, Butani SB. 2019. Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: formulation, optimization and in vivo characterization. J Drug Delivery Sci Technol. 51:214–223. doi: 10.1016/j.jddst.2019.01.040.
  • Ramvikas M, Arumugam M, Chakrabarti SR, Jaganathan KS. 2017. Chapter fifteen—nasal vaccine delivery. Micro and Nanotechnology in Vaccine Development. M. Skwarczynski and I; p. 279–301. Toth, William Andrew Publishing. Norwich, NY.
  • Rao YM, Gayatri P, Ajitha M, Kumar P, Kumar KS. 2017. Chemical permeation enhancers for transdermal delivery of thiocolchicoside: assessment of ex-vivo skin flux and in-vivo pharmacokinetics. PCI- Approved-IJPSN. 10(5):3827–3835. doi: 10.37285/ijpsn.2017.10.5.3.
  • Reuter S, Prasad S, Phromnoi K, Ravindran J, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB. 2010. Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer. Cancer Prevention Research. 3(11):1462–1472. doi: 10.1158/1940-6207.CAPR-10-0037.
  • Rieth MD, Lozano A. 2020. Preparation of DPPC liposomes using probe-tip sonication: investigating intrinsic factors affecting temperature phase transitions. Biochem Biophys Rep. 22:100764. doi: 10.1016/j.bbrep.2020.100764.
  • Ruel-Gariépy E, Leclair G, Hildgen P, Gupta A, Leroux JC. 2002. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Controlled Release. 82(2-3):373–383. doi: 10.1016/S0168-3659(02)00146-3.
  • Ruel-Gariépy E, Leroux JC. 2004. In situ-forming hydrogels–review of temperature-sensitive systems. Eur J Pharm Biopharm. 58(2):409–426. doi: 10.1016/j.ejpb.2004.03.019.
  • Güngör, S. 2009. Sistemik Etki İçin Nazal Yol. Mersin Univ Saglık Bilim Derg. 2(3):7–14.
  • Sakeena MHF, Muthanna FA, Ghassan ZA, Kanakal MM, Elrashid SM, Munavvar AS, Azmin MN. 2010. Formulation and in vitro evaluation of ketoprofen in palm oil esters nanoemulsion for topical delivery. J Oleo Sci. 59(4):223–228. doi: 10.5650/jos.59.223.
  • Samanthula G, Shrigod VV, Patel PN. 2014. Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC. Drug Res (Stuttg). 64(8):429–435. doi: 10.1055/s-0033-1361128.
  • Sensoy D, Cevher E, Sarıcı A, Yılmaz M, Özdamar A, Bergişadi N. 2009. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. Eur J Pharm Biopharm. 72(3):487–495. doi: 10.1016/j.ejpb.2009.02.006.
  • Sherafudeen SP, Vasantha PV. 2015. Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharm Sci. 10(6):466–476.
  • Shingaki T, Hidalgo IJ, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, Yamashita S. 2011. Nasal delivery of P-gp substrates to the brain through the Nose–Brain Pathway. Drug Metab Pharmacokinet. 26(3):248–255. doi: 10.2133/dmpk.DMPK-10-RG-108.
  • Smart JD. 2005. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 57(11):1556–1568. doi: 10.1016/j.addr.2005.07.001.
  • Tas C, Ozkan CK, Savaser A, Ozkan Y, Tasdemir U, Altunay H. 2006. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: in vitro, ex vivo and in vivo evaluation. Eur J Pharm Biopharm. 64(2):246–254. doi: 10.1016/j.ejpb.2006.05.017.
  • Teixeira M, Carbone C, Souto E. 2017. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Prog Lipid Res. 68:1–11. doi: 10.1016/j.plipres.2017.07.001.
  • Thakur N, Kaur B, Goswami M, Sharma C. 2022. Compatibility studies of the Thiocolchicoside with Eudragit RLPO, Eudragit E100 and Eudragit L100 using thermal and non-thermal methods. Drug Comb Ther. 4(1):1–4. doi: 10.53388/DCT2021100301.
  • Toussaint B, Hillaireau H, Cailleau C, Ambroise Y, Fattal E. 2021. Stability, pharmacokinetics, and biodistribution in mice of the EPAC1 inhibitor (R)-CE3F4 entrapped in liposomes and lipid nanocapsules. Int J Pharm. 610:121213. doi: 10.1016/j.ijpharm.2021.121213.
  • Trellu M, Filali-Ansary A, Françon D, Adam R, Lluel P, Dubruc C, Thénot JP. 2004. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans. Fundam Clin Pharmacol. 18(4):493–501. doi: 10.1111/j.1472-8206.2004.00277.x.
  • Ugwoke MI, Agu RU, Verbeke N, Kinget R. 2005. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev. 57(11):1640–1665. doi: 10.1016/j.addr.2005.07.009.
  • Uner BDP, Baranauskaite J. 2022. Ocular delivery systems and applications developed by QbD Perspective: from the Past to the Future. Multidisciplinary Approach in Medical Science II. H. Kafadar; p. 49–63. Turkey, Ankara, Iksad Publishing House.
  • Üner B, Özdemir S, Taş Ç, Özsoy Y, Üner M. 2022. Development of lipid nanoparticles for transdermal loteprednol etabonate delivery. J Microencapsul. 39(4):327–340. doi: 10.1080/02652048.2022.2079744.
  • Upendra, C. G. and D. C. Pravin (2019). Development of metoclopramide hydrochloride in situ gel: nasal delivery and pharmacokinetics in new zealand rabbits. Asian J Pharm Clin Res 12(4): 280–285. doi: 10.22159/ajpcr.2019.v12i4.31779.
  • Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. 2020. Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes. Pharmaceutics. 12(9):859. doi: 10.3390/pharmaceutics12090859.
  • Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. 2009. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 15(23):2724–2750. doi: 10.2174/138161209788923886.
  • Zucker D, Marcus D, Barenholz Y, Goldblum A. 2009. Liposome drugs’ loading efficiency: a working model based on loading conditions and drug’s physicochemical properties. J Control Release. 139(1):73–80. doi: 10.1016/j.jconrel.2009.05.036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.